paclitaxel has been researched along with Endodermal Sinus Tumor in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeMonte, F; El-Naggar, AK; Hanna, EY; Mishra, A | 1 |
| Hayakawa, K; Ishikawa, H; Mitsuhashi, N; Nasu, S; Niibe, H; Nozaki, M; Saito, Y; Sakurai, H; Takahashi, T | 1 |
| Chalas, E; Hindenburg, A; Jeyakumar, A | 1 |
3 other study(ies) available for paclitaxel and Endodermal Sinus Tumor
| Article | Year |
|---|---|
Endodermal sinus tumor of the paranasal sinuses.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Endodermal Sinus Tumor; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Middle Aged; Nasal Obstruction; Neoadjuvant Therapy; Neoplasms, Multiple Primary; Paclitaxel; Paranasal Sinus Neoplasms; Radiotherapy, Adjuvant; Skull Base | 2008 |
Cytotoxic effect of paclitaxel (taxol) either alone or in combination with irradiation in two rat yolk sac tumour cell lines with different radiosensitivities in vitro.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Survival; Combined Modality Therapy; Endodermal Sinus Tumor; Paclitaxel; Radiation Tolerance; Rats; Tumor Cells, Cultured | 1998 |
Sustained complete remission in a patient with platinum-resistant ovarian yolk sac tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Docetaxel; Drug Resistance, Neoplasm; Endodermal Sinus Tumor; Female; Gemcitabine; Humans; Ovarian Neoplasms; Paclitaxel; Taxoids; Thalidomide | 2001 |